We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
(-8.6%)
Cap. Flow
-$5.83B
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$3.97B |
| 2 |
Chevron
CVX
|
+$527M |
| 3 |
Apple
AAPL
|
+$449M |
| 4 |
Morgan Stanley
MS
|
+$426M |
| 5 |
Airbnb
ABNB
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.21B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.87B |
| 3 |
Walmart Inc
WMT
|
+$831M |
| 4 |
Amazon
AMZN
|
+$692M |
| 5 |
Eli Lilly
LLY
|
+$641M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Healthcare | 9.79% |
| 4 | Financials | 6.87% |
| 5 | Industrials | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
SI-BONE Inc
SIBN
$737M
| $2.12M | ﹤0.01% |
168,128
-167,749
| -50% | -$2.62M |
|
|
HPP
1727
Hudson Pacific Properties
HPP
$834M
| $2.12M | ﹤0.01% |
358,610
+263,677
| +278% | +$2.02M |
|
1728
Microchip Technology
MCHP
$42.8B
| $2.12M | ﹤0.01% |
32,799
-1,378,191
| -98% | -$99.1M |
|
1729
Gerdau
GGB
$9.44B
| $2.12M | ﹤0.01% |
586,600
-1,295,850
| -69% | -$5.1M |
|
|
BGSI
1730
Boyd Group Services
BGSI
$2.84B
| $2.11M | ﹤0.01% |
+16,500
| New | +$2.66M |
|
1731
Caleres
CAL
$396M
| $2.1M | ﹤0.01% |
199,451
-270,290
| -58% | -$3.22M |
|
1732
CALL
Expedia Group
EXPE
$31.2B
| $2.1M | ﹤0.01% |
9,100
+5,800
| +176% | +$1.42M |
|
1733
W.R. Berkley
WRB
$28B
| $2.1M | ﹤0.01% |
31,635
+27,402
| +647% | +$1.89M |
|
1734
PACS Group
PACS
$7.42B
| $2.09M | ﹤0.01% |
65,088
-392,807
| -86% | -$14.4M |
|
1735
EyePoint Inc
EYPT
$1.02B
| $2.09M | ﹤0.01% |
+161,784
| New | +$2.42M |
|
|
NIQ
1736
NIQ Global Intelligence PLC
NIQ
$3.17B
| $2.08M | ﹤0.01% |
+183,212
| New | +$2.47M |
|
1737
Williams-Sonoma
WSM
$26.7B
| $2.08M | ﹤0.01% |
+11,410
| New | +$2.28M |
|
1738
YPF
YPF
$20.2B
| $2.08M | ﹤0.01% |
+44,934
| New | +$1.7M |
|
1739
Unusual Machines
UMAC
$925M
| $2.08M | ﹤0.01% |
+167,360
| New | +$2.55M |
|
1740
Sabra Healthcare REIT
SBRA
$5.64B
| $2.08M | ﹤0.01% |
+107,916
| New | +$2.13M |
|
1741
MoonLake Immunotherapeutics
MLTX
$1.59B
| $2.08M | ﹤0.01% |
+111,331
| New | +$1.84M |
|
1742
Arq
ARQ
$86.9M
| $2.07M | ﹤0.01% |
809,705
+365,498
| +82% | +$1.17M |
|
|
FTH
1743
Faeth Therapeutics
FTH
$729M
| $2.07M | ﹤0.01% |
+65,730
| New | +$1.31M |
|
1744
Shinhan Financial Group
SHG
$33.6B
| $2.07M | ﹤0.01% |
33,721
-256,276
| -88% | -$15.7M |
|
1745
Valens Semiconductor
VLN
$176M
| $2.07M | ﹤0.01% |
1,828,381
+38,361
| +2% | +$60.2K |
|
1746
Willdan Group
WLDN
$1.1B
| $2.06M | ﹤0.01% |
26,949
-23,763
| -47% | -$2.51M |
|
1747
Biodesix
BDSX
$228M
| $2.05M | ﹤0.01% |
+141,636
| New | +$1.76M |
|
1748
Artivion
AORT
$1.23B
| $2.05M | ﹤0.01% |
56,009
+51,217
| +1,069% | +$2.02M |
|
1749
Camtek
CAMT
$6.9B
| $2.05M | ﹤0.01% |
+13,504
| New | +$2.05M |
|
1750
Moelis & Co
MC
$4.98B
| $2.04M | ﹤0.01% |
+35,853
| New | +$2.33M |
|
Similar funds
Marshall Wace's Q1 2026 Portfolio in Review
As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.
- Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
- Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
- Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
- Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
- Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
- Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
- Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.